DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based ...
AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.
The $30 million facility was made possible, in part, through a $4 million contribution through the AdventHealth Palm Coast ...
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...
Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Hundreds of FDA-approved drugs tested directly on a patient’s tumor sample. Could this be a gamechanger for cancer management ...
Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.
IntroductionThe global cancer therapeutics market is on an exponential growth trajectory, driven by advancements in treatment ...
The Breast Reconstruction Market has witnessed remarkable advancements in recent years, driven by medical innovations, a ...
Dr. Taylor Theunissen performs autologous breast reconstruction procedures in Baton Rouge, offering cancer survivors natural tissue-based options for post-mastectomy reconstruction with improved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback